Literature DB >> 18005780

Cancer of unknown primary origin: a decade of experience in a community-based hospital.

Jose M Pimiento1, Desarom Teso, Alpin Malkan, Stanley J Dudrick, J Alexander Palesty.   

Abstract

BACKGROUND: Cancer of unknown primary (CUP) origin is a very aggressive disease with a poor prognosis. Most of the literature reports of CUP are generated from tertiary cancer centers.
METHODS: A retrospective chart review of all patients with a diagnosis of CUP was performed between January 1995 and January 2005. Age, gender, diagnostic evaluation, histologic diagnosis, location of metastases, treatment, and survival were recorded.
RESULTS: Ninety-one patients met the inclusion criteria. The pathologic diagnoses included adenocarcinoma (42.8%), undifferentiated carcinoma (34.5%), squamous cell carcinoma (9.8%), neuroendocrine cancer (6.5%), sarcoma (3.2%), and nonspecific malignant neoplasm (3.2%). The overall mean survival was 9.2 months (95% confidence interval, 6.1-12.4 mo), and for squamous cell carcinoma was 26.9 months (standard error, 5.7; P = .007).
CONCLUSIONS: CUP encompasses a variety of different pathologic entities with an overall dismal 5-year survival. Nonetheless, squamous cell and neuroendocrine CUP are associated with a significantly better early prognosis than the other malignancies.

Entities:  

Mesh:

Year:  2007        PMID: 18005780     DOI: 10.1016/j.amjsurg.2007.08.039

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  11 in total

1.  MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.

Authors:  Manuela Ferracin; Massimo Pedriali; Angelo Veronese; Barbara Zagatti; Roberta Gafà; Eros Magri; Maria Lunardi; Gardenia Munerato; Giulia Querzoli; Iva Maestri; Linda Ulazzi; Italo Nenci; Carlo M Croce; Giovanni Lanza; Patrizia Querzoli; Massimo Negrini
Journal:  J Pathol       Date:  2011-06-01       Impact factor: 7.996

2.  A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population.

Authors:  Jia Jin; Xinli Zhou; Xiaohua Liang; Ruofan Huang; Zhaohui Chu; Jingwei Jiang; Qiong Zhan
Journal:  J Neurooncol       Date:  2010-10-27       Impact factor: 4.130

3.  Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Authors:  Federico A Monzon; Fabiola Medeiros; Maureen Lyons-Weiler; W David Henner
Journal:  Diagn Pathol       Date:  2010-01-13       Impact factor: 2.644

4.  Rare form of extraovarian primary peritoneal papillary serous carcinoma with solitary cystic lesion mimicking a liver tumor; report of a case.

Authors:  Yuji Iimuro; Koichiro Ohashi; Kazuhiro Suzumura; Seikan Hai; Shogo Tanaka; Ikuo Nakamura; Yuichi Kondo; Yasukane Asano; Toshihiro Okada; Tadamichi Hirano; Nobukazu Kuroda; Seiichi Hirota; Jiro Fujimoto
Journal:  Clin J Gastroenterol       Date:  2013-01-31

5.  A second-generation microRNA-based assay for diagnosing tumor tissue origin.

Authors:  Eti Meiri; Wolf C Mueller; Shai Rosenwald; Merav Zepeniuk; Elizabeth Klinke; Tina Bocker Edmonston; Margot Werner; Ulrike Lass; Iris Barshack; Meora Feinmesser; Monica Huszar; Franz Fogt; Karin Ashkenazi; Mats Sanden; Eran Goren; Nir Dromi; Orit Zion; Ilanit Burnstein; Ayelet Chajut; Yael Spector; Ranit Aharonov
Journal:  Oncologist       Date:  2012-05-22

6.  Clinical Outcomes in Patients with Cancer of Unknown Primary Site Treated By Gastrointestinal Oncologists.

Authors:  Sakiko Yamane; Chikatoshi Katada; Satoshi Tanabe; Mizutomo Azuma; Kenji Ishido; Takafumi Yano; Takuya Wada; Akinori Watanabe; Natsuko Kawanishi; Yasuaki Furue; Yuki Kondo; Shouko Komori; Hiromichi Ishiyama; Kazushige Hayakawa; Wasaburo Koizumi
Journal:  J Transl Int Med       Date:  2017-03-31

7.  A case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumor.

Authors:  Yuichi Ozeki; Yoshiyuki Abe; Hideyuki Kita; Katsumi Tamura; Ikuko Sakata; Jiro Ishida; Kikuo Machida
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

8.  RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.

Authors:  Iris H Wei; Yang Shi; Hui Jiang; Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2014-11-20       Impact factor: 5.715

9.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

10.  A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer.

Authors:  Issei Kurahashi; Yoshihiko Fujita; Tokuzo Arao; Takayasu Kurata; Yasuhiro Koh; Kazuko Sakai; Koji Matsumoto; Maki Tanioka; Koji Takeda; Yuichi Takiguchi; Nobuyuki Yamamoto; Asuka Tsuya; Nobuaki Matsubara; Hirofumi Mukai; Hironobu Minami; Naoko Chayahara; Yasuhiro Yamanaka; Keisuke Miwa; Shin Takahashi; Shunji Takahashi; Kazuhiko Nakagawa; Kazuto Nishio
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.